IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Pagnesi, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 292
EU - Europa 269
NA - Nord America 264
SA - Sud America 3
AF - Africa 2
OC - Oceania 2
Totale 832
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 262
HK - Hong Kong 133
IT - Italia 95
SG - Singapore 79
CN - Cina 60
DE - Germania 53
FI - Finlandia 46
IE - Irlanda 25
GB - Regno Unito 24
CZ - Repubblica Ceca 7
FR - Francia 6
JP - Giappone 5
IN - India 3
TR - Turchia 3
UA - Ucraina 3
CA - Canada 2
ID - Indonesia 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PE - Perù 2
TN - Tunisia 2
VN - Vietnam 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NL - Olanda 1
SE - Svezia 1
Totale 832
Salva come PNG Salva come JPEG
Città #
Hong Kong 130
Chandler 67
New York 50
Singapore 47
Beijing 34
Helsinki 31
Dublin 25
Princeton 24
Shanghai 20
Milan 18
Lappeenranta 15
Ashburn 14
Brescia 14
London 11
Rome 7
Brno 6
Strasbourg 6
West Jordan 6
Padova 5
Curno 4
Frankfurt am Main 4
Kilburn 4
Venice 4
Washington 4
Azzano San Paolo 3
Lviv 3
Munich 3
Potsdam 3
Tokyo 3
Acton 2
Bari 2
Berlin 2
Bernareggio 2
Boardman 2
Calcinato 2
Castrezzato 2
Christchurch 2
Costa Masnaga 2
Fairfield 2
Gavardo 2
Ho Chi Minh City 2
Istanbul 2
Leipzig 2
Lima 2
Montesilvano Marina 2
North Bergen 2
Pisogne 2
Prescot 2
Sandigliano 2
Sidoarjo 2
Toscolano-Maderno 2
Tunis 2
Agropoli 1
Almaty 1
Baku 1
Brembate di Sopra 1
Central 1
Coimbatore 1
Colombo 1
Des Moines 1
Fornovo San Giovanni 1
Gambassi Terme 1
Hounslow 1
Kashan 1
Lariano 1
Los Angeles 1
Luxembourg 1
Madrid 1
Miami 1
Montreal 1
Nanjing 1
Newark 1
Oklahoma City 1
Olomouc 1
Pontedera 1
Pune 1
San Diego 1
San Francisco 1
Santiago 1
Sarajevo 1
Seattle 1
Sofia 1
Sopron 1
Stockholm 1
Stoney Creek 1
Tallinn 1
Tower Hamlets 1
Verona 1
Viareggio 1
Zagreb 1
Totale 649
Salva come PNG Salva come JPEG
Nome #
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 35
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 29
Vericiguat for Heart Failure with Reduced Ejection Fraction 29
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 28
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors 27
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 22
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 22
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 21
Prognostic significance of serum potassium in patients hospitalized for acute heart failure 21
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 21
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum 21
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 21
Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation 20
February 2021 at a glance: focus on amyloidosis, myocarditis and cardiomyopathy 17
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 17
March 2021 at a glance: focus on epidemiology, prevention and COVID-19 16
Combined pre- and post-capillary pulmonary hypertension in left heart disease 16
Hepatic T1-time, cardiac structure and function and cardiovascular outcomes in patients with dilated cardiomyopathy 16
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial 15
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 15
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 14
Prognostic role of tricuspid annular plane systolic excursion/pulmonary artery systolic pressure ratio in patients hospitalized for acute heart failure 14
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 13
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 13
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 13
High troponin levels in patients hospitalized for coronavirus disease 2019: a maker or a marker of prognosis? 13
Ejection fraction in heart failure: just become Emperor's new clothes? 13
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure 12
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 12
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 12
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 11
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial 11
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 11
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists 11
Intra-Aortic Balloon Pumping in Acute Decompensated Heart Failure With Hypoperfusion: From Pathophysiology to Clinical Practice 11
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial 10
Heart failure: an update from the last years and a look at the near future 10
Medical therapy for heart failure with preserved ejection fraction: Still a minefield, but with new hope 10
Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves 10
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 10
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 10
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis 10
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients with Pre Cardiogenic Shock 9
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 9
Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review 9
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure 9
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction 9
Right ventricular thrombosis: from a case report to pathophysiology mechanisms and current treatment options 8
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 7
2024 update in heart failure 7
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 7
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry 7
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 7
NT-proBNP and high-intensity care for acute heart failure: the STRONG-HF trial 7
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF 7
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 7
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial 7
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial 7
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 6
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 6
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial 6
Reply to "Clinical implications of left atrial changes after optimization of medical therapy in heart failure patients" 6
Is it NICE to measure natriuretic peptides after a hospitalization for heart failure? 5
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 5
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 5
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 5
Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction 5
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial 5
Noncardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG-HF trial 5
Impact of malnutrition in patients with severe heart failure 4
Prognostic role of mitral regurgitation in patients with advanced heart failure 4
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk 3
Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial 2
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 2
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial 2
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE 2
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 2
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 2
Functional Mitral Regurgitation and Heart Failure With Preserved Ejection Fraction: Clinical Implications and Management 2
Totale 890
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.338
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202236 0 0 0 0 2 1 2 0 2 0 3 26
2022/2023206 23 21 4 6 15 56 2 16 26 1 13 23
2023/2024638 27 11 52 33 30 71 42 17 150 21 51 133
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 890